Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
| Actual shortage: | 243 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2445 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-MOMETASONE | 0.1% | OINTMENT | Actual shortage | 2024-02-29 | 2024-06-07 | 220986 |
| TEVA-SIMVASTATIN | 5MG | TABLET | Actual shortage | 2023-07-11 | 2024-06-07 | 198303 |
| TEVA-SIMVASTATIN | 5MG | TABLET | Actual shortage | 2023-08-17 | 2024-06-07 | 202252 |
| TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-01-25 | 2024-06-07 | 217231 |
| TEVA-CINACALCET | 90MG | TABLET | Actual shortage | 2024-04-11 | 2024-06-07 | 224913 |
| ACT METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-05-16 | 2024-06-07 | 228143 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Actual shortage | 2024-03-07 | 2024-06-07 | 221537 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Actual shortage | 2024-03-07 | 2024-06-07 | 221534 |
| TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-05-03 | 2024-06-07 | 226945 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-01-11 | 2024-06-07 | 215751 |
| TEVA-RIVAROXABAN | 20MG | TABLET | Actual shortage | 2024-05-09 | 2024-06-07 | 227456 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-28 | 2024-06-07 | 223856 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-04-05 | 2024-06-07 | 224445 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2024-05-09 | 2024-06-07 | 227459 |
| TEVA-ZOPICLONE | 5MG | TABLET | Resolved | 2023-02-02 | 2024-06-07 | 183386 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2023-06-19 | 2024-06-07 | 195652 |
| TEVA-TOPISONE | 0.05% | CREAM | Actual shortage | 2024-06-07 | 2024-06-07 | 229939 |
| TEVA-BUSPIRONE | 10MG | TABLET | Actual shortage | 2024-06-07 | 2024-06-07 | 229945 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Actual shortage | 2024-06-07 | 2024-06-07 | 229948 |
| TEVA-MELOXICAM | 15MG | TABLET | Actual shortage | 2024-06-07 | 2024-06-07 | 229951 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |